This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

FDA Mulls Ban on Newports, Menthol Cigarettes

Stocks in this article: LO MO RAI PM

(Potential menthol cigarette ban report updated with response from Altria Group (MO - Get Report).)
GREENSBORO, N.C. ( TheStreet) -- Lorillard (LO - Get Report), Reynolds American (RAI - Get Report) and Altria Group (MO - Get Report) have been on the rise in recent sessions after a Food and Drug Administration panel did not specifically suggest the agency should ban menthol cigarettes.

The Tobacco Products Scientific Advisory Committee, the FDA panel, did say on March 18 that the removal of menthol cigarettes from the American cigarette market would improve the overall health of the nation, but did not go as far as to suggest a complete ban of the flavored smokes. "The availability of menthol cigarettes has adverse impact on public health by increasing the numbers of smokers," the panel said, adding that it "has no specific suggestions" on how to proceed based on its assertions.

The 2009 Family Smoking Prevention and Tobacco Control Act stipulated that tobacco makers could not add candy-like flavors such as cloves and vanilla to their products, but left the menthol debate up to the FDA.

An "undue emphasis on reduction of menthol relative to other cigarettes may distract from the ultimate health-prevention message that smoking of any cigarettes is injurious to health," the panel said.

A report from the panel is expected to be delivered to the FDA any day now, though the FDA has no deadline to make a decision about a ban on menthols.

Altria Client Services on behalf of Philip Morris USA sent a written report to the FDA summarizing its response to the panel's findings.

The Philip Morris report found that its "review of the science- and evidence-based information demonstrates that regulatory actions or restrictions related to the use of menthol in cigarettes are neither necessary nor justified."

"Significant restrictions, like eliminating menthol in cigarettes, would not reduce the population harm caused by cigarette smoking, and would lead to severe and lasting unintended consequences detrimental to public health objectives and society."

1 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs